Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial

NCT00147264 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Syndrome X

Interventions

DRUG: Telmisartan (Micardis®) vs. Placebo
BEHAVIORAL: Low-Glycemic Index Diet vs. Control Diet

Sponsor

McMaster University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]